CRA is a proud exhibiting sponsor of this event.
Cecile Matthews is presenting during the session titled “What is the relationship between price and prevalence in non-oncology rare disease?”
Greg Bell is presenting during the session titled “Simplifying patient tracking,” showcasing RD Navigator.
For more information on this event, click here.
CRA's RADAR Insights: Impact of US pricing strategies on orphan drug pricing in Germany - Part 3
In Part 3 of this series, RADAR data on orphan-drug pricing in Germany revealed a significant increase in manufacturer-set list prices for new orphan drugs...